Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $2.44 billion. The enterprise value is $3.94 billion.
| Market Cap | 2.44B |
| Enterprise Value | 3.94B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 140.93 million shares outstanding. The number of shares has increased by 0.65% in one year.
| Current Share Class | 140.93M |
| Shares Outstanding | 140.93M |
| Shares Change (YoY) | +0.65% |
| Shares Change (QoQ) | -0.94% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 22.54% |
| Float | 21.65M |
Valuation Ratios
The trailing PE ratio is 16.80 and the forward PE ratio is 13.57. Ardent Health's PEG ratio is 2.57.
| PE Ratio | 16.80 |
| Forward PE | 13.57 |
| PS Ratio | 0.38 |
| Forward PS | 0.37 |
| PB Ratio | 1.75 |
| P/TBV Ratio | 5.45 |
| P/FCF Ratio | 8.64 |
| P/OCF Ratio | 5.06 |
| PEG Ratio | 2.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.82, with an EV/FCF ratio of 13.95.
| EV / Earnings | 26.93 |
| EV / Sales | 0.61 |
| EV / EBITDA | 7.82 |
| EV / EBIT | 11.69 |
| EV / FCF | 13.95 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 1.27.
| Current Ratio | 2.13 |
| Quick Ratio | 1.40 |
| Debt / Equity | 1.27 |
| Debt / EBITDA | 2.95 |
| Debt / FCF | 8.02 |
| Interest Coverage | 6.42 |
Financial Efficiency
Return on equity (ROE) is 13.52% and return on invested capital (ROIC) is 8.13%.
| Return on Equity (ROE) | 13.52% |
| Return on Assets (ROA) | 4.01% |
| Return on Invested Capital (ROIC) | 8.13% |
| Return on Capital Employed (ROCE) | 7.77% |
| Weighted Average Cost of Capital (WACC) | 4.75% |
| Revenue Per Employee | $256,113 |
| Profits Per Employee | $5,802 |
| Employee Count | 25,200 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 22.76 |
Taxes
In the past 12 months, Ardent Health has paid $60.36 million in taxes.
| Income Tax | 60.36M |
| Effective Tax Rate | 20.73% |
Stock Price Statistics
The stock price has increased by +17.93% in the last 52 weeks. The beta is 0.58, so Ardent Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +17.93% |
| 50-Day Moving Average | 11.44 |
| 200-Day Moving Average | 10.12 |
| Relative Strength Index (RSI) | 85.26 |
| Average Volume (20 Days) | 740,140 |
Short Selling Information
The latest short interest is 3.75 million, so 2.66% of the outstanding shares have been sold short.
| Short Interest | 3.75M |
| Short Previous Month | 4.58M |
| Short % of Shares Out | 2.66% |
| Short % of Float | 17.34% |
| Short Ratio (days to cover) | 7.62 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.45 billion and earned $146.22 million in profits. Earnings per share was $1.03.
| Revenue | 6.45B |
| Gross Profit | 3.82B |
| Operating Income | 336.78M |
| Pretax Income | 291.19M |
| Net Income | 146.22M |
| EBITDA | 503.20M |
| EBIT | 336.78M |
| Earnings Per Share (EPS) | $1.03 |
Balance Sheet
The company has $766.24 million in cash and $2.27 billion in debt, with a net cash position of -$1.50 billion or -$10.64 per share.
| Cash & Cash Equivalents | 766.24M |
| Total Debt | 2.27B |
| Net Cash | -1.50B |
| Net Cash Per Share | -$10.64 |
| Equity (Book Value) | 1.78B |
| Book Value Per Share | 9.91 |
| Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was $481.88 million and capital expenditures -$199.57 million, giving a free cash flow of $282.30 million.
| Operating Cash Flow | 481.88M |
| Capital Expenditures | -199.57M |
| Depreciation & Amortization | 166.42M |
| Net Borrowing | -9.49M |
| Free Cash Flow | 282.30M |
| FCF Per Share | $2.00 |
Margins
Gross margin is 59.14%, with operating and profit margins of 5.22% and 2.27%.
| Gross Margin | 59.14% |
| Operating Margin | 5.22% |
| Pretax Margin | 4.51% |
| Profit Margin | 2.27% |
| EBITDA Margin | 7.80% |
| EBIT Margin | 5.22% |
| FCF Margin | 4.37% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.65% |
| Shareholder Yield | -0.65% |
| Earnings Yield | 5.95% |
| FCF Yield | 11.58% |
Analyst Forecast
The average price target for Ardent Health is $15.21, which is -12.08% lower than the current price. The consensus rating is "Buy".
| Price Target | $15.21 |
| Price Target Difference | -12.08% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 3.59% |
| EPS Growth Forecast (3Y) | -2.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.07 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 6 |